Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BIO-TECHNE (TECH) Invested Capital: 2010-2025

Historic Invested Capital for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $2.0 billion.

  • BIO-TECHNE's Invested Capital fell 8.08% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year decrease of 8.08%. This contributed to the annual value of $1.9 billion for FY2025, which is 7.25% down from last year.
  • BIO-TECHNE's Invested Capital amounted to $2.0 billion in Q3 2025, which was up 2.45% from $1.9 billion recorded in Q2 2025.
  • BIO-TECHNE's Invested Capital's 5-year high stood at $2.1 billion during Q3 2024, with a 5-year trough of $1.8 billion in Q3 2022.
  • Over the past 3 years, BIO-TECHNE's median Invested Capital value was $2.0 billion (recorded in 2023), while the average stood at $2.0 billion.
  • In the last 5 years, BIO-TECHNE's Invested Capital fell by 9.69% in 2022 and then climbed by 13.70% in 2023.
  • Over the past 5 years, BIO-TECHNE's Invested Capital (Quarterly) stood at $2.0 billion in 2021, then decreased by 7.97% to $1.8 billion in 2022, then climbed by 7.47% to $2.0 billion in 2023, then grew by 5.85% to $2.1 billion in 2024, then dropped by 8.08% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q3 2025, $1.9 billion for Q2 2025, and $2.0 billion during Q1 2025.